Circle Cardiovascular Releases Latest Version of Unified Cardiac Imaging Platform

Jan. 27. 2026 — Circle Cardiovascular Imaging Inc. has announced the release of cvi42 v6.4, the latest version of its post-processing software. This release reinforces Circle CVI’s commitment to providing a single, seamless platform that powers faster, more reproducible and efficient cardiac imaging processing.

cvi42 v6.4 introduces major new capabilities designed to streamline workflows, enhance diagnosis and support reimbursement opportunities through improved automation and reproducibility.

With this release, Circle CVI advances its vision of complete cardiovascular imaging integration:

• Advanced CMR Automation for precise tissue characterization, including enhanced T1 mapping workflows and 4D flow pre-processing for faster, high-quality results.
• Plaque Analysis for deeper coronary characterization and risk assessment.
• Pericoronary Adipose Tissue (PCAT) tools for research-use analysis of perivascular inflammation.
• PowerScribe One Integration, enabling direct reporting and improved workflow continuity between imaging and structured reporting systems.
• Vascular CT Analysis and Planning tools, expanding Circle CVI’s breadth across cardiology and vascular imaging, and enabling aortic, carotid, and peripheral arteries evaluation, pre-procedural planning and follow up.

cvi42 is engineered for workflow optimization — allowing cardiac teams to interpret studies faster, with greater reproducibility and accuracy. These improvements enable more consistent, data-driven reporting and contribute to increased throughput and reimbursement potential.

“Our customers demand the highest accuracy and consistency in cardiovascular imaging,” said Scott Galbari, Chief Product Officer, Circle CVI. “With cvi42 v6.4, we are extending the reach of our single-platform solution to help clinicians deliver faster, reproducible results, while improving productivity and the quality of patient care.”

With the new Category I CPT code for AI-enabled quantitative coronary plaque analysis now active and major insurers reimbursing the procedure, cvi42 provides practices with an on-premise, FDA-cleared AI solution that integrates seamlessly into existing CCTA workflows enabling practices to capture the newly available reimbursement.

Circle CVI’s Elevate pricing structure allows practices to deploy cvi42 as part of a flexible subscription that scales across CT and MR service lines, spreading software costs across a broader cardiovascular imaging portfolio. By aligning licensing with volume and growth, Elevate helps organizations convert reimbursement into sustainable margin, funding further investment in staff, technology, and service expansion.

cvi42 v6.4 is available globally.